The Interaction between three anthracycllne antibiotics of second generation (9-deoxydoxorublcin, 9-DAM, 4-demethoxydaunorublcin, 4-DDM, 4'-deoxydoxorubicin, 4'-DAM) and DNA in the nucleosomal structure was investigated using fluorescence and circular dichrolsm techniques. The thermodynamlc parameters of the binding process were obtained at different ionic strength and temperature conditions, thus allowing the calculation of the electrostatic contribution to the free energy and the enthalpy of the process. The same measurements were performed on linear double stranded DNA for comparison. The parent compounds adriamycin and daunomycln were additionally considered. Although the examined drugs greatly vary in biological activity, their binding parameters are only slightly different. Like the parent compounds, 9-DAM, 4-DDM and 4'-DAM exhibit preference for isolated regions of the polynucleotide rather than for nucleosomes. This fact suggests a non-homogeneous distribution of the antibiotics In vivo. The enthalpy values are remarkably lower than the ones characterizing the interaction of adriamycin and daunomycin to DNA. According to CD spectra, all derivatives, but 4-DDM, intercalate into nucleosomal or free DNA in a manner similar to the first generation compounds, namely with the chromophore perpendicular to the hydrogen bonds between the bases. The demethoxy compound, on the other hand, seems to be able to insert its planar moiety in different orientations, which are related to the structure of the nucleic acid being examined. The lack of the methoxy group in the intercalating part of the molecule appears to be responsible for this behaviour. As far as biological activity is concerned, our findings indicate a qualitative correlation between cell cytotoxicity and ability of interaction with nucleosomes at physiological conditions, rather than with free DNA. The modified binding stereochemistry of 4-DDM could play an additive role in modulating the pharmacological effectiveness of the above compounds.
INTRODUCTION
Although anthracycline antibiotics have always received much attention and their clinical use is widespread, the fundamental question of how they primarily act has not found a definitive answer as yet. Several hypotheses have been considered: interaction with DNA (1, 2), binding to membranes (3, 4) , inhibition of replicative enzymes (5, 6) , free radical production (7, 8) and chelation of metal ions (9, 10) . In particular, the poisoning effects caused on topoisomerases have been shown to play relevant role in cell cytotoxicity (11, 12) . Clearly all of these phenomena are interrelated and may contribute to the pharmacological properties of this class of compounds. In particular binding to DNA can interfere both with enzymatic reactions and with strand-breakage of the nucleic acid caused by free radicals originated from the anthracycline or its metalcomplex. Thus an investigation aimed at characterizing the process of interaction with DNA is still basically relevant. Only a very few reports deal with the binding process of anticancer drugs to structures closer to the in vivo arrangement of DNA, rather than simply to the 'free' double helical nucleic acid (13, 14) . In these papers 175 bp nucleosomes have been used as a suitable model for chromatin. Important effects of DNA structure on drug binding have been pointed out, which could be related to the biological activity of anthracycline antibiotics.
To gain further insight into the dependence of anticancer drug binding upon DNA structure, a physico-chemical characterization of complex formation between three second generation anthracyclines and nucleosomal or 'free' double stranded DNA has been performed. The chemical structure of the drugs examined ( Figure 1 ) is modified at positions 9, 4, 4' with reference to the parent compounds adriamycin and daunomycin. These modifications cause substantial changes in the pharmacological behavior of the above derivatives. In particular, compound 9-DAM is only weakly active, while the others are very effective, the order of response being:
MATERIALS AND METHODS
9-DAM, 4-DDM and 4'-DAM have been kindly supplied by Farmitalia Carlo Erba (Milano) as the hydrochlorides. Stock
• To whom correspondence should be addressed solutions were obtained by dissolving the drugs in low ionic strength buffer. Molar extinction coefficients respectively of 10690 M-'cm-' at 485 nm, 10920 M^'cm" 1 at 480 nm and 12200 M" 1 cm" 1 at 480 nm have been calculated from a Lambert-Beer plot. They were routinely used to determine the concentration of the antibiotics. The absence of precipitates or changes in the absorption spectra of the stock solutions were regularly verified.
Highly purified calf thymus DNA was purchased from Sigma as lyophilised. It was sonicated to average molecular weight of about 250,000, corresponding to a length of -400 base pairs. Solutions were prepared by swelling it (~ 1 mg/ml) overnight at 4°C in low ionic strength buffer, then filtering and adjusting the concentration to the desired value with buffer. An extinction coefficient of 6800 M~'cm~' has been considered.
175 bp calf thymus nucleosomes were prepared as described in the literature (14) and used immediately after preparation. The length of the DNA fragments and the presence of the histones in the correct ratio were controlled with gel electrophoresis techniques, whereas circular dichroism spectra were used to confirm the nucleosomal structure (15) .
Buffers at three different ionic strength (0.022, 0.104, 0.355 M) have been used. They were prepared by dissolving the correct amount of sodium chloride, Carlo Erba, in TE buffer (10 mM TRIS, Fluka, 1 mM EDTA, Carlo Erba, pH 7).
Measurements were performed on a Perkin Elmer MPF-66 spectrofluorimeter interfaced with a Perkin Elmer 7500 Data Station, using cell quartz of 1 cm optical pathway. Titrations were conducted at 11 °C, 25°C, 40°C using a Haake F3C thermostate. When operating at low temperature, nitrogen was kept fluxing in the cell compartment in order to avoid moisture condensation on the cell walls. All solutions were filtered through 3 urn Millipore filters prior to use. Emission spectra of the samples were recorded using an excitation wavelength of 480 nm (close to the maximum of the drugs absorption spectra) or 510-540 nm (corresponding to the isosbestic region of the absorption spectra for the mixtures anthracycline-DNA). No appreciable change has been noticed in the evaluation of the data using either wavelength value. Intensity of fluorescence was read at the wavelength of maximum emission, usually in the 540-590 nm range. The titrations were performed adding to the sample, containing initially ~ 10~4 M nucleic acid, weighed amounts of a stock drug solution in order to generate DNA/anthracycline ratios decreasing from 100 to 1. The fluorescence response of bound drug was obtained by extrapolating the data at high P/D ratio to infinite DNA concentration. The experimental values, corrected for dilution, were elaborated according to McGhee and Von Hippel (16) and represented as Scatchard plots (17) .
Circular dichroism studies were performed on a JASCO J 500 spectropolarimeter interfaced with a JASCO mod. 501 N Data Processor, using quartz cuvettes of 1 cm optical pathway. In the visible region (650-320 nm) every sample was scanned four times with 1 m°/cm sensitivity, whereas in the UV zone (320-200 nm) two accumulations and 2 m°/cm sensitivity were used. When investigating the behaviour of the visible band of anthracyclines upon complexation, the samples were prepared adding DNA to a solution of antibiotic (~10~5 M). When working at shorter wavelength, the drug was added to the macromolecule at ~ 10~4 M. All spectra were corrected for dilution.
RESULTS
The affinity of anthracyclines for nucleosomes and 'free' double stranded DNA was evaluated by fluorescence spectroscopy measurements. In fact the emission of the drug is almost completely quenched in the presence of the nucleic acid. Measurements were performed at different ionic strength and temperature conditions. Representative Scatchard plots are shown in Figures 2 and 3 . At very low binding ratios (r < 0.02) all plots seem to be indicative of the presence on the polynucleotide of a limited number of sites with very high affinity. Unfortunately, the high intrinsic error in measurements at so low r values renders these experimental data not sufficiently reliable to draw quantitative conclusions. However it is worth mentioning that recent data by Chaires and coworkers are strongly suggestive of DNA sites with high affinity for daunomycin (18) .
Effects of ionk strength
The values (per base) of the intrinsic interaction constant Kj and of the exclusion parameter n (16) for the system under investigation at different salt concentrations are reported in Table  I (nucleosomes) and Table n (free DNA). The data relative to the same experimental conditions for the parent compounds adriamycin and daunomycin are included for comparison. A complete agreement is found with the results reported by Chaires et al. (14) for the latter compound. The binding parameters for the complex between 9-DAM and isolated DNA at low ionic strength could not be obtained. This is due to an unusual Tables I and n. behaviour of the fluorescence titration with this anthracycline derivative. In fact, as the ratio DNA/drug becomes smaller, the intensity of the emission signal does not increase monotonically. No apparent modifications in the shape of the spectrum occur. This unusual trend is not observed at higher ionic strength.
The exclusion parameter n is not substantially modified using the different antibiotics or organized nucleic acid instead of isolated double stranded DNA. No cooperativity effects are observed except for the complex 4'-DAM-DNA at low ionic strength. The values of K, are of the order of 10 5 for all of the second generation anthracyclines. As for the parent compounds, the intrinsic constants are higher when the nucleic acid is not structurally organized. These differences suggest an unequal distribution among regions of the polynucleotide in vivo. Still, the magnitude of this effect varies for the different drugs (for example, the ratio between K; with isolated DNA and nucleosomes at low ionic strength for 4-DDM is ~ 8 whereas for 4'-DAM is less than 2). An evaluation of this parameter at physiological ionic strength could be more informative. The Table IV . Thermodynamic binding parameters for the interaction between anthracycline derivatives and nucleosomal or isolated DNA at *0.022 M ionic strength, pH 7 and different temperatures. The estimated error is 10%.
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•)at low ionic strengths moderate positive cooperativity (w=6) is observed. values of Kj at this salt concentration have been obtained by interpolation for all systems. The ratios between the intrinsic interaction constants with isolated DNA and nucleosomes are reported in Table HI . From the slope of the diagram of log K, vs. log (ionic strength), shown in Figure 4 , we obtain an indication of the fraction of phosphate groups involved in electrostatic interactions with the protonated amino group of daunosamine (19) (20) (21) . It is worth noticing that 9-DAM behaves very similarly to the parent compounds, while the electrostatic interaction seems to be less efficient for 4-DDM and 4'-DAM. In all cases the effect is less pronounced when the nucleic acid is structurally organized.
Temperature effects
The thermodynamic parameters for the complexes between second generation anthracyclines and double stranded or nucleosomal DNA at different temperatures are reported in Table  IV . The exclusion coefficients are only slightly affected by this factor, but the intrinsic interaction constant values decrease in all cases as temperature increases. The data for the system 9-DAM-DNA are not available for the reasons previously exposed. The enthalpy factors obtained from the van't Hoff plots, are reported in Table V . For free DNA, these values are smaller than the ones relative to the parent compounds. A very interesting behaviour is the enthalpy modulation upon changing from isolated to nucleosomal DNA. For the complex between 4-DDM and the latter the enthalpy is less favorable (-15 kJ/mol) in comparison to the binding to the double helix, but for 4'-DAM the opposite trend is observed. Geometry of intercalated complexes Circular dichroism studies have been performed to evaluate the possibility of different geometries of complexation with DNA and nucleosomes, related to differences in chemical structure of the anthracycline derivatives investigated.
In the range 320-200 nm the spectral changes occurring upon addition of the anthracycline to DNA are related to structural modifications of the nucleic acid, in addition to contributions from the drug, which is optically active. To avoid overlapping of the latter contributions, we examined the modifications in the CD spectra of DNA and nucleosomes in the presence of sufficiently low drug concentrations (about 20 fold lower than DNA). In all cases, irrespective of the nature of the anthracycline being examined, the eUipticity of the positive band at 275 nm increases when the drug is added. The phenomenon is comparable using either free DNA or nucleosomes ( Figure 5 ). The intensity of the above band has been shown to be sensitive to the winding angle in a double helical DNA structure (22) . Our findings confirm that unwinding caused by intercalation is similar for the examined drugs (23) . The fact that nucleosomes behave similarly to free DNA in this test confirms the general preference for intercalation into protein-free regions, as previously discussed. In addition, no spectral changes occur in the far UV region, where histone contributions are largely predominant. Thus the conformation of the protein core is not appreciably modified by drug binding to nucleosomes.
Induced circular dichroism in the ligand absorption region can give useful informations on the orientation of the transition moment of the drug in the intercalation pocket (24) . An increase in eUipticity of the visible band upon addition of DNA is observed for 9-DAM and 4'-DAM ( Figure 6 ). This fact is comparable with a more or less perpendicular arrangement between the axis of the planar chromophore and the hydrogen bonds of the bases for these two compounds. The same behaviour was found for AM and DM, whose 'perpendicular' geometry of insertion in the intercalation pocket is already established by X-ray structural analysis (25) . The spectral modifications are not affected by the structural organization of the nucleic acid, suggesting a similar geometry for the binding of anthracyclines either to isolated DNA or to nucleosomes. The situation changes considerably for 4-DDM ( Figure 7 ). The ellipticity of the visible band of this derivative slightly increases upon addition of isolated DNA, but decreases upon addition of nucleosomes. In this compound the methoxy group, which represents a serious steric hindrance factor for the aromatic portion in the intercalation complex, is absent. It appears safe to conclude that the anthraquinone moiety of 4-DDM assumes a different orientation in the intercalated complex as a function of nucleic acid structure.
DISCUSSION
Examining the binding parameters obtained at different ionic strength and temperature conditions for the complexes between 9-DAM, 4-DDM, 4'-DAM and isolated or nucleosomal DNA, some interesting conclusions can be drawn. Assuming that anthracyclines bind to the linker region of 175 bp nucleosomes essentially as to the free double helix, we could in principle calculate the binding parameters relative to the core particle only. However, this kind of evaluation does not consider the possibility of local deformations of the helical geometries, like kinks, at the border between the two regions, modifications which can affect the strength and the geometry of the binding. For these considerations we have limited our comparison to the constants with isolated DNA and the overall values for nucleosomes. A preference of the investigated derivatives for the protein-free nucleic acid is evident. The reasons for this behaviour might be related to a modification in the mechanism of interaction, to a change in the electrostatic contribution to the binding and/or to changes in the insertion of the anthracycline chromophore between the bases of the nucleosome. The first hypothesis has to be excluded at least for 9-DAM and 4'-DAM since the spectral properties of the complex with nucleosomes and with isolated DNA are practically the same. On the other hand, it is highly unlikely that intercalation be no longer preferred when the planar part does not contain the methoxy group as in 4-DDM. The diminishing of the electrostatic contribution, for all of the systems investigated, upon changing from isolated to nucleosomal DNA is expected if we consider that in the core particle about half of the negative phosphate charges are counterbalanced by the basic residues of the histone proteins. Less obvious is the different electrostatic contribution to complex formation exhibited by the derivatives under investigation. 4-DDM and, especially, 4'-DAM show a remarkably lower dependence of Kj upon salt concentration in comparison to 9-DAM or the parent first generation anthracyclines. The explanation is likely to be found in a different geometry of intercalation for 4-DDM. Since the absence of the OH group in 4' position leads to a stronger NH 2 base with respect to the parent compounds (1), electronic effects cannot account for the reduced electrostatic contribution to the complex with 4'-DDM. Apparently, stereochemical factors related to the orientation of the sugar ring in the minor groove may play a major role in the dependence of Kj on ionic strength. Alternatively, modifications of the hydrogen bonding pattern in the absence of the 4'-OH substitution could explain the observed behaviour.
Another interesting question is how and how much the structural organization of the polynucleotide affects the enthalpy of the process. The interaction of 4-DDM with DNA is characterized by a lower enthalpy value in comparison to adriamycin and daunomycin. The complex between this derivative and nucleosomes is 15 kJ/mol less stable than the complex with isolated DNA, this effect being perhaps related to the different geometry of intercalation. For 9-DAM it is possible to calculate only the enthalpy of interaction with the structurally organized polynucleotide. The resulting value is slightly less favorable than for the system 4-DDM-nucleosomes. When the drug used is 4'-DAM, the enthalpy factor is much lower with both isolated and nucleosomal DNA. Interestingly, the enthalpic contribution to the stability of the complex with the latter seems to be somewhat higher. Nevertheless, a direct comparison is not safe, taking into account the presence of cooperativity effects when using the free polynucleotide at low ionic strength.
The effects of the chemical structure of the anthracycline on the geometry of the intercalation complexes have been pointed out by circular dichroism studies. In particular, 9-DAM and 4'-DAM behave similarly to the parent compounds, positioning the long axis of the chromophore perpendicularly to the hydrogen bonds between the bases. If we consider that the third derivative lacks the bulky methoxy group in position 4, we might expect different orientations of the planar moiety of the drug in the hydrophobic pocket without substantial loss of energy of binding. In the nucleosomal structure, the local narrowing and widening of the minor groove may 'force' the chromophore to adopt an alternative binding geometry. This is in agreement with linear dichroism studies on the interaction of 4-DDM with DNA (26) .
The last point to be examined is the relationship between interaction with nucleic acids and biological activity of anthracycline antibiotics. Among the derivatives investigated, 9-DAM is poorly active, whereas 4-DDM and 4'-DAM exhibit the highest cytotoxicity. The values of the intrinsic interaction constants, interpolated at physiological conditions, show a better correlation with biological activity considering the complexes with nucleosomes rather than with free DNA. In any event, the lack of hydrogen bonding ability at position 9 is not causing as dramatic changes in the DNA-binding properties of 9-DAM, as it might be expected from pharmacological data.
The derivatives examined until now are too few to draw general conclusions. It appears however that a combined thermodynamic and sterochemical analysis of the interaction of a large number of drug derivatives with DNA at different levels of structural organization and, possibly, a chemical characterization of ternary DNA-enzyme-drug complexes, would yield further valuable insight into the mechanism of action of anthracycline antibiotics.
